Specifications tableSubject areaBiologyMore specific subject areaCancer biologyType of dataFiguresHow data was acquiredABI 7500 qPCR, western blot analysis, Image J softwareData formatAnalyzedExperimental factorsAdsorption of matrix proteins to PUR substrates, gene expression after silencing or over expressingExperimental featuresGene expression of altered and unaltered bone-metastatic cancer cells was analyzedData source locationNashville, TN USAData accessibilityThe data is presented in this article and is related to \[cite our article\]

Value of the data•Utilizing different matrix proteins shows that the bone destructive gene expression is highly specific to fibronectin.•Manipulation of Integrin expression affects *PTHrP* and *Gli2* gene expression.•Genetic manipulation of Integrin expression of MDA-MB-231 cells does not alter other metastatic pathways or the growth potential of the cell lines.

1. Data {#s0005}
=======

1.1. Gene expression changes in response to rigidity {#s0010}
----------------------------------------------------

The bone-metastatic breast cancer cell line MDA-MB-231, bone-metastatic lung cancer cell line RWGT2, and the bone-metastatic prostate cancer cell line PC3 were used to test the effects of matrix rigidity on gene expression of the bone destructive genes, *PTHrP* and *Gli2*. Integrin β3 was either over expressed by an Iβ3 construct or inhibited in the MDA-MB-231 cell line by genetic inhibition using a shRNA construct or pharmacological inhibition with LM609 or Cilengitide [@bib1].

In addition to gene expression changes, *Gli2* protein increases with respect to matrix rigidity ([Fig. 1](#f0005){ref-type="fig"}A). While Integrin gene expression changes correlate with rigidity [@bib2], in the bone-metastatic MDA-MB-231 cells, *Iβ1* and *Iβ5* do not respond to matrix rigidity while *Iβ3* increases with increasing substrate modulus ([Fig. 1](#f0005){ref-type="fig"}B D). Thus the cells are interacting with the matrix primarily through *Iβ3*.

1.2. Effects of adhesion Molecules on bone metastatic gene expression {#s0015}
---------------------------------------------------------------------

Expression of *Iβ3*, *Gli2*, and *PTHrP* by MDA-MB-231 cells cultured on 2D compliant and rigid films and normalized to values measured for compliant films is shown in [Fig. 2](#f0010){ref-type="fig"}. With the exception of *PTHrP* expression on films treated with poly(L-lysine), no significant differences were observed between rigid and compliant films for poly(L-lysine), vitronectin, or type I collagen.

1.3. Inhibiting Iβ3 decreases *PTHrP* and *Gli2* gene expression {#s0020}
----------------------------------------------------------------

Genetic inhibition of *Iβ3* with shRNA in MDA-MB-231 cells decreased *Gli2* protein levels ([Fig. 3](#f0015){ref-type="fig"}A). Additionally, pharmacological inhibition with LM609 or Cilengitide decreased *Gli2* protein levels ([Fig. 3](#f0015){ref-type="fig"}B and C). Similar results were seen for *PTHrP* and *Gli2* when RWGT2 (black) or PC3 (white) cells were treated with LM609 or Cilengitide ([Fig. 3](#f0015){ref-type="fig"}D--G).

1.4. Molecular modulation of Iβ3 expression {#s0025}
-------------------------------------------

OE β3 cells showed increased *PTHrP* expression compared to mock-transfected control cells ([Fig. 4](#f0020){ref-type="fig"}A). Additionally, when cultured on rigid and compliant PUR films, the OE β3 cells showed no statistical difference in *PTHrP* gene expression ([Fig. 4](#f0020){ref-type="fig"}B). Thus, the OE β3 and shβ3 cells were utilized as model cell systems with high and low Integrin expression, respectively ([Figs. 4](#f0020){ref-type="fig"}C and D).

1.5. Effects of matrix rigidity on *TGF-β RII* expression {#s0030}
---------------------------------------------------------

Expression of *TGF-β RII* by MCF-7 (negative control), MDA-MB-231, and RWGT2 cells was measured by qPCR on rigid and compliant substrates. As anticipated, expression of *TGF-β RII* was significantly lower in MCF-7 cells compared to MDA-MB-231 and RWGT2 cells. There were no significant differences in expression as a function of matrix rigidity for any of the three cell types ([Fig. 5](#f0025){ref-type="fig"}A).

1.6. Effects of Fn concentration on physical interactions between *Iβ3* and *TGF-βRII* {#s0035}
--------------------------------------------------------------------------------------

The effects of Fn concentration on the FRET signal in MDA-MB-231 cells was measured for Fn concentrations ranging from 0--50 μg/ml. The FRET signal was significantly higher on rigid substrates at all Fn concentrations ([Fig. 5](#f0025){ref-type="fig"}B).

1.7. Exogenous TGF-β stimulation of *PTHrP* and *Gli2* is *Iβ3*-dependent {#s0040}
-------------------------------------------------------------------------

To investigate the role of TGF-β signaling in *Iβ3* regulation of *PTHrP* and *Gli2*, RWGT2 or PC3 cells were treated with the Integrin inhibitory antibody LM609 and given exogenous TGF-β. *PTHrP* and *Gli2* were analyzed by qPCR. TGF-β stimulates *PTHrP* and *Gli2* mRNA expression in RWGT2 (black) or PC3 (white) cells, but is unable to stimulate expression when *Iβ3* is inhibited with LM609 ([Fig. 6](#f0030){ref-type="fig"}A and B) suggesting that both TGF-β and *Iβ3* are required for regulating *PTHrP* and *Gli2*.

1.8. Effects of silencing *Iβ3* on growth of and bone metastatic gene expression by MDA-MB-231 tumor cells {#s0045}
----------------------------------------------------------------------------------------------------------

As shown in [Fig. 7](#f0035){ref-type="fig"}A, shβ3 cells exhibited a growth rate similar to that of the mock-transfected control. With the exception of Osteopontin (Opn), expression of bone metastatic genes by shβ3 cells was similar to that by mock-transfected control cells ([Fig. 7](#f0035){ref-type="fig"}B).

2. Experimental design, materials, and methods {#s0050}
==============================================

2.1. Western blot analysis {#s0055}
--------------------------

Cells were harvested 24 h after seeding on PUR substrates in a radioimmunoprecipitation buffer containing a cocktail of protease and phosphatase inhibitors (Pierce). Equal protein concentrations were prepared for loading with NuPAGE sample buffer (Life Technologies) and separated on a 10% SDS-PAGE gel (BioRad). Proteins were transferred to a PVDF membrane and blocked with 5% BSA in TBS containing 0.1% Tween-20 for 1 h at room temperature, followed by incubation with anti-*Gli2* antibody (1:1000, SantaCruz) overnight at 4 °C. After washing, membranes were blotted with anti-goat IgG (1:2000, SantaCruz), and bands were detected by enhanced chemiluminescence using an In-Vivo MS FX Pro (Bruker). Membranes were then stripped and reprobed using an antibody for β-actin (1:5000, Sigma) as a loading control. Analysis was performed using Image J software.

2.2. Quantitative real-time PCR {#s0060}
-------------------------------

To measure changes in gene expression, mRNA reverse transcription was carried out using the qScript cDNA synthesis kit (Quanta, VWR) per manufacturer׳s instructions. Briefly, cells were harvested with trypsin after 24 h in culture and total RNA was extracted using the RNeasy Mini Kit (Qiagen). The qScript cDNA supermix was used to synthesize cDNA using 1 µg total RNA. The expression of *PTHrP*, *Gli2*, *Iβ1, Iβ3, Iβ5,* and *TGF-β RII* was measured in triplicate by quantitative qRT-PCR using validated TaqMan primers with the 7500 Real-Time PCR System (Applied Biosciences) using the following cycling conditions: 95 °C for 15 s and 60 °C for 1 min, preceded by an initial incubation period of 95 °C for 10 min. Quantification was performed using the absolute quantitative for human cells method using 18S as an internal control.

2.3. Adsorption of adhesion molecules {#s0065}
-------------------------------------

In addition to fibronection (Fn), compliant and rigid PUR films were incubated with a 4 µg/mL solution of vitronectin, type I collagen, or poly(L-lysine) in PBS overnight at 4 °C to mediate cell adhesion. MDA-MB-231 cells were cultured on the films for 48 h. Expression of *Iβ3*, *Gli2*, and *PTHrP* was measured by qPCR relative to the control 18S.

![(A) *Gli2* protein expression increases with respect to substrate modulus. (B--D) Integrin β3 mRNA expression changes with increasing substrate modulus, while there is no change in Integin β1 and Integrin β5. (\**p*\<0.05, \*\**p*\<0.01, \*\*\**p*\<0.005). *N*=3 biological replicates. Data presented as fold change over 3.8×10^6^ kPa for each gene.](gr1){#f0005}

![Expression of *PTHrP*, *Gli2*, and *Iβ3* by MDA-MB-231 cells on compliant and rigid PUR films treated with poly(L-lysine), vitronectin, or type I collagen. Gene expression was measured by qPCR. Data presented as fold change over compliant films.](gr2){#f0010}

![*Gli2* western blot for (A) shβ3 cells or (B--C) MDA-MB-231 cells treated with Cilentide or LM609. (D--G) *PTHrP* (D-E) or *Gli2* (F-G) mRNA expression for RWGT2 cells (black) or PC3 cells (white) treated with Cilengitide or LM609. (\**p*\<0.05, \*\**p*\<0.01). *N*=3 biological replicates. Data presented as fold change over untreated.](gr3){#f0015}

![Expression of *PTHrP* and *Iβ3* in genetically modified MDA-MB-231 cells. (A) OE β3 cells over-express *Iβ3* compared to the mock-transfected control. (B) Effect of rigidity on expression of *PTHrP* by OE β3 cells. (C) shβ3 cells express significantly low *Iβ3* compared to the mock-transfected control. (D) OE β3 cells express significantly higher *Iβ3* compared to the mock-transfected control. (^⁎^*p*\<0.05, ^⁎⁎^*p*\<0.01). *N*=3 biological replicates. Data presented as fold change over untreated or compliant.](gr4){#f0020}

![(A) Effects of matrix rigidity on TGF-β RII expression by MCF-7 (white), MDA-MB-231 (gray) and RWGT2 (black) cells. (B) Effects of Fn concentration on the FRET signal for MDA-MB-231 cells.](gr5){#f0025}

![(A) *PTHrP* and (B) *Gli2* mRNA expression for RWGT2 (black) or PC3 (white) cells treated with LM609 and given exogenous TGFβ. (\**p*\<0.05, \*\**p*\<0.01, \*\*\**p*\<0.005). *N*=3 biological replicates. Data presented as fold change over untreated.](gr6){#f0030}

![Effects of silencing *Iβ3* on tumor cell growth and bone metastatic gene expression. (A) Cell growth. (B) Bone metastatic gene expression.](gr7){#f0035}
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